| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6201295 | Ophthalmology | 2014 | 8 Pages |
Abstract
The AREDS supplements reduced the rate of AMD progression across all genotype groups. Furthermore, the genotypes at the CFH and ARMS2 loci did not statistically significantly alter the benefits of AREDS supplements. Genetic testing remains a valuable research tool, but these analyses suggest it provides no benefits in managing nutritional supplementation for patients at risk of late AMD.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
Emily Y. MD, Michael L. MD, Traci E. PhD, Elvira MA, Rinki PhD, Albert O. MD, PhD, Lars G. PhD, Anand PhD, Gonçalo R. PhD, Age-Related Eye Disease Study Research Group Age-Related Eye Disease Study Research Group,